Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by NOVO NORDISK INC
FDA Drug Application 020741 by NOVO NORDISK INC
Application Number
020741
Application Type
New Drug Application
Sponsor Applicant
NOVO NORDISK INC
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Priority
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
12/22/1997
N
AP
0
8/10/1999
SLR
AP
0
3/1/1999
SCE
AP
0
5/18/1999
SCS
AP
0
5/18/1999
SCS
AP
0
8/30/1999
SCM
AP
0
12/8/1999
SCM
AP
0
11/26/1999
SCS
AP
0
2/25/2000
SCM
AP
0
8/15/2000
SCM
17084
009
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020741_S009_PRANDIN_TABS_AP.pdf
7/6/2007
AP
0
10/27/2000
SCS
AP
0
1/18/2002
SE8
3563
012
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20741s12ltr.pdf
1/18/2002
AP
0
1/18/2002
SE8
3565
012
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20741s12lbl.pdf
1/18/2002
AP
0
10/21/2002
SE1
3567
013
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20741se1-013ltr.pdf
10/21/2002
AP
0
10/21/2002
SE1
3568
013
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20741s13lbl.pdf
10/21/2002
AP
0
8/5/2002
SCE
AP
0
10/1/2002
SCS
17080
015
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020741_S015_PRANDIN_TABS_AP.pdf
7/6/2007
AP
0
11/25/2002
SCE
17081
016
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020741_S016_PRANDIN_TABS_AP.pdf
7/6/2007
AP
0
8/27/2003
SLR
6580
018
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20741slr018ltr.pdf
8/29/2003
AP
0
8/27/2003
SLR
6588
018
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20741slr018_prandin_lbl.pdf
8/29/2003
AP
0
10/15/2003
SCP
6817
019
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20741scp019ltr.pdf
10/17/2003
AP
0
10/15/2003
SCP
17083
019
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020741_S019_PRANDIN_TABS_AP.pdf
7/6/2007
AP
0
2/10/2005
SLR
11109
022
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20741s022lbl.pdf
2/11/2005
AP
0
2/10/2005
SLR
11115
022
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/20741s022ltr.pdf
2/11/2005
AP
0
6/19/2006
SLR
14365
030
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020741s030LTR.pdf
6/28/2006
AP
0
6/19/2006
SLR
17082
030
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/020741_S030_PRANDIN_TABS_AP.pdf
7/6/2007
AP
0
7/14/2008
SLR
20207
034
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020741s034lbl.pdf
7/15/2008
AP
0
7/14/2008
SLR
20209
034
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020741s034ltr.pdf
7/15/2008
AP
0
6/10/2009
SLR
22756
035
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020741s035ltr.pdf
6/16/2009
AP
0
6/10/2009
SLR
22778
035
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020741s035lbl.pdf
6/22/2009
AP
0
7/29/2010
SLR
26076
038
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020741s038lbl.pdf
7/31/2010
AP
0
7/29/2010
SLR
26100
038
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020741s038ltr.pdf
8/3/2010
AP
0
3/1/2012
SLR
32026
040
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020741s040ltr.pdf
3/5/2012
AP
0
3/1/2012
SLR
32043
040
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020741s040lbl.pdf
3/6/2012
AP
0
10/30/2015
SCM
Back to FDA Applications sponsored by NOVO NORDISK INC